The vaccine against Coronavirus: Germany approves first human trials

Covid-19's clinical trials in Germany have been approved, the Federal Institute for Vexina of this end said. This will result in 200 healthy people between the ages of 18 and 55 receiving different variants of the vaccine as scientists examine its efficiency in providing immunity against the deadly virus. [...]
This will result in 200 healthy people between the ages of 18 and 55 receiving different variants of the vaccine as scientists examine its efficiency in providing immunity against the deadly virus.
The race is in the development of a vaccine that will be able to help contain the distribution of the coronary, which so far has killed over 177 thousand people in the world and infected 2.5 million others, according to figures from John Hopkins University, Periscope is sent.
The World Health Organization said there are at least 20 different vaccines against the current coronarys, including some in clinical testing. /Periscope












